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ards models were then used to determine the mortality risk
of the AIDS-deﬁning illnesses before and after adjustment
for potential confounders. The relative hazards of death
were then ranked to check for consistency of ﬁndings. The
analysis was ﬁrst carried out for all AIDS-deﬁning illnesses,
and repeated so as to compare the survival of initial AIDS-
deﬁning illness diagnosed at the time of AIDS diagnosis, and
those diagnosed thereafter.
Results: The results showed poor median survival for
patients with AIDS-deﬁning illnesses of HIV encephalopathy,
unspeciﬁed pneumonias, Lymphoma and Kaposi’s Sarcoma.
The hazard ratios in the multivariate models for each of
these AIDS-deﬁning illnesses were signiﬁcantly higher than
2. The ranking of AIDS-deﬁning illnesses in terms of sur-
vival pattern was noted to be generally consistent even after
adjusting for prognostic factors such as age at diagnosis of
AIDS and number of AIDS-deﬁning illnesses.
Conclusion: We ranked AIDS-deﬁning illnesses according
to adjusted hazard ratios, which showed that clear rank-
ing had been generally maintained. This study serves as an
important reference in evaluating the use of AIDS-deﬁning
illness for assessment, prognostication and management of
AIDS patients.
doi:10.1016/j.ijid.2008.05.394
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Purpose: To provide a summary of the trends of HIV infec-
tion among the nations of Southeast Asia.
Methods: The US Census Bureau compiled databases
(December 2006 version) were analyzed for the nations of
Southeast Asia. Linear trends established by regression were
compared by risk factor status through time.
Findings: Data from 11 nations were analyzed ranging
from 39,702 studies in Thailand to 5 in East Timor. Mean
HIV prevalences among all studies were highest in Cambodia
(11.1), Myanmar (10.7) and Thailand (10.2). Among the gen-
eral population, highest prevalences were seen in Cambodia
(3.02) and Thailand (1.74). Linear trends showed highest val-
ues for Viet Nam and Malaysia (both 0.96), although with
sample size weighing the highest was for Cambodia (0.75).
Risk factor groups with highest overall prevalence (exclud-
ing hemophiliacs) were drug using populations in Myanmar
(54.3), Thailand (35.2), Viet Nam (26.0), Indonesia (25.7),
and Malaysia (16.98), and commercial sex workers (CSW) in
Cambodia (27.3), Myanmar (18.8), and Thailand (13.4). In
Thailand, HIV prevalence increased signiﬁcantly among TB
patients (25.8 to 42.1) but fell among CSWs (16.5 to 10.3).
Using linear trend regression analysis, greatest increases
in prevalence were seen among drug using populations in
Indonesia (3.9) and Viet Nam (2.44) and among sexually
treated infection patients in Cambodia (2.3). Decreases in
HIV prevalence were seen among CSW populations in Cam-
bodia (−1.01) and Thailand post-1997 (−1.18). Linear trends
by regression among heterosexually acquired HIV were high-
est in Myanmar (2.13) and the Thai outbreak pre-1998 (1.61).
Conclusions: The HIV epidemic impacts selected popula-
tions in different nations in Southeast Asia. Signiﬁcant gains
in Thailand post-1998 are not shared throughout the region
with rises in prevalence among drug using populations in
Indonesia and Viet Nam. Decreases among CSW populations
in Cambodia are not reﬂected among the trends seen in
Cambodian STI clinics.
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Purpose: To provide an analysis of HIV cases among the
drug using populations in the nations of Southeast Asia.
Methods: The US Census Bureau compiled databases
(December 2006 version) for HIV among drug using popula-
tions were analyzed for the nations of Southeast Asia. Linear
and quadratic models were formed and compared by risk
factor status.
Findings: Signiﬁcant data were available for 6 of the
11 nations of SE Asia (Brunei, Cambodia, East Timor, Laos
and Singapore are not represented). The compiled studies
included signiﬁcant numbers from Thailand (1002), Viet Nam
(308), Myanmar (140), Malaysia (65), the Philippines (52)
and Indonesia (36). The overall prevalences for HIV in the
drug-using populations were highest for Myanmar (54.3) and
Thailand (32.5 before 1998, 35.2 1998 and later) and Indone-
sia (25.7) followed by Viet Nam (20.0) and Malaysia (12.1).
The compiled rate was very low for the Philippines (0.07
with 1.6 the highest reported prevalence). The linear trends
obtained as a measure on linear regression showed the high-
est values for Indonesia (3.9 where 21 of 36 studies are from
Jakarta and all Jakarta studies are 1995 or later) followed by
Viet Nam (2.44), Thailand before 1998 (1.72), and Malaysia
(1.3) and Thailand 1998 and later (1.10), Decreasing values
(showing falling prevalence among studies) were reported
from Myanmar (with a high baseline) (−0.28) and the Philip-
pines (−0.007). Quadratic best-ﬁt curves for Malaysia and
Indonesia are shown below.
Conclusions: Advances in HIV/AIDS control among drug-
using populations in Southeast Asia are not uniform. The
nation most impacted is Myanmar and its high prevalences
are associated with some modest decline in recent stud-
ies. The recent upsurge in Indonesia is primarily in Jakarta.
Nations not reporting data require additional surveillance
for the geographically abut the above impacted nations.
doi:10.1016/j.ijid.2008.05.396
